(Q81505084)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15759168%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

[Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15759168%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

squamous cell carcinoma

1 reference

T K Hoffmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15759168%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

T L Whiteside

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15759168%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

H Bier

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15759168%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15759168%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15759168%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15759168%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15759168%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

285-97; quiz 298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15759168%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00106-004-1167-0

9 January 2020

exact match

0 references

cites work

Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform

1 reference

12 December 2020

The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patients

1 reference

12 December 2020

Monoclonal antibodies against surface antigens of laryngeal carcinoma cells (author's transl)

1 reference

12 December 2020

First results of a randomized trial on immunotherapy of head and neck tumors

1 reference

12 December 2020

The A9 antigen associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin alpha 6 beta 4

1 reference

12 December 2020

Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study

1 reference

12 December 2020

Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

1 reference

12 December 2020

Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins

1 reference

12 December 2020

Transfer of interleukin 2 receptor genes into squamous cell carcinoma. Modification of tumor cell growth.

1 reference

12 December 2020

Interferon gamma induced oncolysis. An effect on head and neck squamous carcinoma cultures.

1 reference

12 December 2020

MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

Phase Ib trial of the effect of peritumoral and intranodal injections of interleukin-2 in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial

1 reference

12 December 2020

Gene therapy for head and neck cancer

1 reference

12 December 2020

Impairment of T-cell activation in head and neck cancer in situ and in vitro: strategies for an immune restoration

1 reference

12 December 2020

Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies

1 reference

12 December 2020

Adjuvant Trial of Levamisole in Patients With Squamous Cancer of the Head and Neck: A Preliminary Report

1 reference

12 December 2020

p53: a potential target antigen for immunotherapy of cancer

1 reference

12 December 2020

Comparison of in vivo and in vitro prostaglandin E2 production by squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Adoptive immunotherapy for head and neck cancer with killer cells induced by stimulation with autologous or allogeneic tumour cells and recombinant interleukin-2

1 reference

12 December 2020

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck

1 reference

12 December 2020

The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer

1 reference

12 December 2020

Head and Neck Squamous Cell Carcinoma Cell Line-Induced Suppression of in vitro Lymphocyte Proliferative Responses

1 reference

12 December 2020

Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration.

1 reference

12 December 2020

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphatically

1 reference

12 December 2020

[Clinical and experimental investigation on the effect of lyophilized Trypanosoma cruzi extracts on certain forms of cancer.]

1 reference

12 December 2020

Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor

1 reference

12 December 2020

The immunopharmacology of head and neck cancer: an update

1 reference

12 December 2020

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

1 reference

12 December 2020

Epidermal growth factor family receptors and inhibitors: radiation response modulators

1 reference

12 December 2020

Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones

1 reference

12 December 2020

Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer.

1 reference

12 December 2020

Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.

1 reference

12 December 2020

Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.

1 reference

12 December 2020

Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas.

1 reference

12 December 2020

Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

1 reference

12 December 2020

Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

1 reference

12 December 2020

Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants

1 reference

12 December 2020

Gene therapy--phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol

1 reference

12 December 2020

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

1 reference

12 December 2020

Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial

1 reference

12 December 2020

Immunobiology and immunotherapy of head and neck cancer

1 reference

12 December 2020

The effects of prostaglandins on the proliferation of cultured human T lymphocytes

1 reference

12 December 2020

Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts

1 reference

12 December 2020

Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx

1 reference

12 December 2020

Isolation and purification of a squamous cell carcinoma of the head and neck-associated antigen identified by autologous antibody

1 reference

12 December 2020

A Randomized Trial of Adjuvant BCG Immunotherapy in Head and Neck Cancer

1 reference

12 December 2020

Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

12 December 2020

Targeting head and neck cancer by GM-CSF-mediated gene therapy in vitro.

1 reference

12 December 2020

The humoral response to the tumor-suppressor gene-product p53 in human cancer: implications for diagnosis and therapy

1 reference

12 December 2020

Clinical significance of defective dendritic cell differentiation in cancer

1 reference

12 December 2020

The feasibility of radioimmunotherapy of head and neck cancer

1 reference

12 December 2020

Adoptive immunotherapy by intra-arterial infusion of ATLAK or Allo-TLAK cells in patients with head and neck cancer

1 reference

12 December 2020

Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer

1 reference

12 December 2020

Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell

1 reference

12 December 2020

Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.

1 reference

12 December 2020

Phase I-II study of advanced head and neck squamous cell carcinoma patients treated with recombinant human interferon gamma

1 reference

12 December 2020

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

1 reference

12 December 2020

P53(110-124)-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cells

1 reference

12 December 2020

Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck

1 reference

12 December 2020

The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40

1 reference

12 December 2020

The Ability of Variant Peptides to Reverse the Nonresponsiveness of T Lymphocytes to the Wild-Type Sequence p53264-272 Epitope

1 reference

12 December 2020

Tumor-induced death of immune cells: its mechanisms and consequences

1 reference

12 December 2020

Production of a monoclonal antibody (K 931) to a squamous cell carcinoma associated antigen identified as the 17-1A antigen

1 reference

12 December 2020

Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas

1 reference

12 December 2020

Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients

1 reference

12 December 2020

Inhibition of head and neck metastatic and/or recurrent cancer by local administration of multi-cytokine inducer OK-432

1 reference

12 December 2020

Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck

1 reference

12 December 2020

Antibodies to human squamous cell carcinoma

1 reference

12 December 2020

Levamisole in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9.

1 reference

12 December 2020

Chemotherapy versus chemoimmunotherapy of head and neck cancer: report of a randomized study

1 reference

12 December 2020

Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors

1 reference

12 December 2020

SQM1 antibody defines a surface membrane antigen in squamous carcinoma of the head and neck

1 reference

12 December 2020

Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2

1 reference

12 December 2020

Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2

1 reference

12 December 2020

Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma

1 reference

12 December 2020

Application of human leucocyte interferon in patients with tumours of the head and neck

1 reference

12 December 2020

Clinical results of leukocyte interferon-induced tumor regression in resistant human metastatic cancer resistant to chemotherapy and/or radiotherapy-pulse therapy schedule

1 reference

12 December 2020

Production of monoclonal antibodies to squamous cell carcinoma antigens

1 reference

12 December 2020

[Monoclonal antibody UW 21/123: clinical use and diagnostic specificity in head and neck cancers]

1 reference

12 December 2020

The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer

1 reference

12 December 2020

In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody

1 reference

12 December 2020

The expression of epidermal growth factor receptors in the oral mucosa of patients with oral cancer

1 reference

12 December 2020

Chemoimmunotherapy for cancer of the head and neck

1 reference

12 December 2020

Signaling defects in T lymphocytes of patients with malignancy

1 reference

12 December 2020

Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group

1 reference

12 December 2020

Analysis of individual specific cytotoxic T lymphocytes for two MAGE-3-derived epitopes presented by HLA-A24

1 reference

12 December 2020

Significance of C1q-binding macromolecules within the head and neck cancer patient

1 reference

12 December 2020

Local adoptive immunotherapy of advanced head and neck tumors with LAK cells and interleukin-2.

1 reference

12 December 2020

Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody

1 reference

12 December 2020

Dose-dependent access of murine anti-epidermal growth factor receptor monoclonal antibody to tumor cells in patients with advanced laryngeal and hypopharyngeal carcinoma

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer

1 reference

12 December 2020

[Induction of antitumor immune response in the mouse model after vaccination with B7.1 expressing tumor cells]

1 reference

12 December 2020

Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin

1 reference

12 December 2020

Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cells

1 reference

12 December 2020

Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer

1 reference

12 December 2020

Tumoricidal effect of human PBMC following stimulation with OK-432 and its application for locoregional immunotherapy in head and neck cancer patients

1 reference

12 December 2020

Head and neck cancer antigens recognized by the humoral immune system

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

Penetration of tumor tissue by antibodies and other immunoproteins

1 reference

12 December 2020

Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

1 reference

12 December 2020

Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells

1 reference

12 December 2020

Mechanisms responsible for signaling and functional defects.

1 reference

12 December 2020

Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte-macrophage colony-stimulating factor and B7-1 genes

1 reference

12 December 2020

Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.

1 reference

12 December 2020

Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences

1 reference

12 December 2020

Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer

1 reference

12 December 2020

Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG

1 reference

12 December 2020

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

12 December 2020

Interleukin-2 injected around tumor-draining lymph nodes in head and neck cancer

1 reference

12 December 2020

Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells

1 reference

12 December 2020

Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity

1 reference

12 December 2020

Expression of the MAGE gene family in human head‐and‐neck squamous‐cell carcinomas

1 reference

12 December 2020

Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer

1 reference

12 December 2020

Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity

1 reference

12 December 2020

Immunohistochemical detection of retroviral-P15E-related material in carcinomas of the head and neck

1 reference

12 December 2020

An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma

1 reference

12 December 2020

Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events

1 reference

12 December 2020

Antiproliferative effects of cytokines on squamous cell carcinoma

1 reference

12 December 2020

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells

1 reference

12 December 2020

EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.

1 reference

12 December 2020

Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.

1 reference

12 December 2020

Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer

1 reference

12 December 2020

Autocrine secretion and malignant transformation of cells.

1 reference

12 December 2020

Evaluation of therapeutic potential of interleukin 2-expanded tumor-infiltrating lymphocytes in squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial

1 reference

12 December 2020

The role of Fas/FasL in immunosuppression induced by human tumors

1 reference

12 December 2020

Production of a suppressor of lymphocyte proliferation by two human oral carcinoma cell lines

1 reference

12 December 2020

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

12 December 2020

A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes

1 reference

12 December 2020

Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer

1 reference

12 December 2020

Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cells

1 reference

12 December 2020

Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition

1 reference

12 December 2020

p53-based immunotherapy of cancer

1 reference

12 December 2020

Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens.

1 reference

12 December 2020

Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer

1 reference

12 December 2020

Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin/5-fluorouracil

1 reference

12 December 2020

Cellular sources of transforming growth factor-alpha in human oral cancer

1 reference

12 December 2020

Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2

1 reference

12 December 2020

Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma

1 reference

12 December 2020

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer

1 reference

12 December 2020

Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas.

1 reference

12 December 2020

Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines

1 reference

12 December 2020

Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing

1 reference

12 December 2020

Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinoma

1 reference

12 December 2020

Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experience

1 reference

12 December 2020

IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response

1 reference

12 December 2020

Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells

1 reference

12 December 2020

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

12 December 2020

Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.

1 reference

12 December 2020

Clinical trial of Corynebacterium parvum (intra-lymph-node and intravenous) and radiation therapy in the treatment of head and neck carcinoma

1 reference

12 December 2020

Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma

1 reference

12 December 2020

EpCAM: A New Therapeutic Target for an Old Cancer Antigen

1 reference

12 December 2020

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy

1 reference

12 December 2020

Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance

1 reference

12 December 2020